Condition: Symptomatic Neuroma · Phantom Limb Pain After Amputation · Residual Limb Pain · Sponsor: Saglik Bilimleri Universitesi
This prospective, observational cohort study evaluates the long-term outcomes of Regenerative Peripheral Nerve Interface (RPNI) surgery in patients with major lower extremity amputations suffering from symptomatic neuromas. RPNI is a surgical technique where the transected nerve end is implanted into a free autologous muscle graft to serve as a physiological target for reinnervation. The study aims to objectively assess the reduction in mechanical hypersensitivity using Pressure Pain Threshold (PPT) measurements via a digital algometer. Additionally, it monitors subjective neuropathic pain levels, functional mobility, and prosthesis satisfaction over a 24-month follow-up period compared to pre-operative baselines.
This description comes directly from the study's public registry record.
Ahmet Burak Bilekli, MD, Associate Professor · +905326007020 · draburakbilekli@yahoo.com
Muhammed Burak Polat, MD · +90 545 340 73 23 · draburakbilekli@yahoo.com
Always discuss trial participation with your own doctor first.
| University of Health Sciences, Gulhane Training and Research Hospital, Department of Orthopedics and Traumatology | Ankara, Ankara, Turkey (Türkiye) | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07420192